Transparency and Accountability of Decision-Making

Drug Pharmaceutical policy development, including drug review decisions, must be accessible and open to the general public, patients and all physicians.

The development, implementation and evaluation of pharmaceutical policy must include meaningful and formal processes for involving informed patients, specialty physicians and, when appropriate, members of the public.